US20020026080A1 - Synthesis of N,N-disubstituted-p-phenylenediamine - Google Patents
Synthesis of N,N-disubstituted-p-phenylenediamine Download PDFInfo
- Publication number
- US20020026080A1 US20020026080A1 US09/760,202 US76020201A US2002026080A1 US 20020026080 A1 US20020026080 A1 US 20020026080A1 US 76020201 A US76020201 A US 76020201A US 2002026080 A1 US2002026080 A1 US 2002026080A1
- Authority
- US
- United States
- Prior art keywords
- dspda
- addition salt
- acid addition
- oxygen
- dbpda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/06—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
- C07C209/10—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to carbon atoms of six-membered aromatic rings or from amines having nitrogen atoms bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/30—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
- C07C209/32—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups
- C07C209/36—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups by reduction of nitro groups bound to carbon atoms of six-membered aromatic rings in presence of hydrogen-containing gases and a catalyst
Definitions
- the invention relates to an improved synthesis of N,N-disubstituted-p-phenylenediamine, especially the dibutyl form (DBPDA).
- DBPDA is a useful reagent in colorometric and fluorescence assays.
- U.S. Pat. No. 6,066,467 discloses the use of a particular N,N-disubstituted-p-phenylene diamine, DBPDA, in a fluorescence assay for hydrogen sulfide production from the action of homocysteinase.
- the assay which is useful to measure homocysteine levels in bodily fluids, shows enhanced sensitivity over similar assays which utilize absorbance by color.
- Such assays are described in U.S. Pat. No. 5,998,191 and U.S. Pat. No. 5,985,540, also incorporated by reference.
- the colorometric reagent counterparts to DBPDA, in addition to this dibutyl derivative can also be N,N-dipropyl-1,4-phenylenediamine or the corresponding diethyl or dimethyl derivative.
- DBPDA dibutyl derivative
- the invention is directed to an improvement over the literature-described synthesis of di-n-butyl-p-phenylenediamine and its salts, as well as DSPDA in general.
- the improved method like that described in the prior art, employs the conversions shown in FIG. 1. Both the intermediate nitroso-compound and the phenylenediamine derivative that is the final product can be converted to the acid addition salts using standard techniques. According to the method of the present invention, certain steps in this reaction are conducted in an oxygen-free environment.
- the invention is directed to an improved method to synthesize DSPDA, especially DBPDA, which method comprises treating p-nitroso disubstituted aniline with a reducing agent, and working up the product in the absence of oxygen.
- the reducing agent is zinc.
- the production of the nitroso compound is preferably from treating disubstituted aniline starting material with nitrous acid.
- the invention is directed to an improved method to crystallize DSPDA, especially DBPDA, which method comprises treating an absolute ethanol solution of the dihydrochloride with ether.
- FIG. 1 shows the steps in the conversion of di-n-butylaniline to DBPDA.
- an aqueous solution of the starting material preferably di-n-butylaniline is acidified with concentrated acid, preferably HCl, and then treated with sodium nitrite.
- the temperature is kept low, preferably at 0° C., and the addition of sodium nitrite to the starting material solution is performed with stirring over 1-2 hours.
- the crude hydrochloride product precipitates from solution and may, if desired, be re-crystallized.
- the recovered di-n-butyl-p-nitrosoaniline hydrochloride prepared is then dissolved in hydrochloric acid and a reducing agent added.
- a preferred reducing agent is excess zinc dust, although other reducing agents, such as H 2 could also be used.
- the zinc metal is filtered off. It is essential to the method of the invention that the filtrate, from then on, is kept under an atmosphere which excludes oxygen. The filtrate is neutralized with strong base. If zinc is used as a reducing agent, the zinc ion formed initially precipitates and then re-dissolves. During this process, the reaction mixture is kept under nitrogen or other method to exclude oxygen is employed.
- the hydrochloride salt can then be crystallized by dissolving in an alcoholic solvent in the absence of water and in the absence of oxygen and effecting crystallization by addition of ether.
- the DBPDA product can be refluxed in acetone at 70-80° for about two hours.
- the resulting DBPDA is useful as a reagent for the colorometric or fluorescence detection of hydrogen sulfide in the presence of a metal ion, such as ferric ion, as described in the above-cited art.
- dialkyl substituted phenylene diamines are useful in fluorescence detection of hydrogen sulfide in the presence of a metal ion or other oxidizing agent.
- the method described above with particularity for DBPDA is also useful for N,N-disubstituted phenylene diamines in general which also have utility as detection reagents in such assays.
- the method could be applied to any dialkyl substituted form, as well as forms of the phenylene diamine which have substituents on the ring nitrogen which may themselves be substituted alkyl groups.
- the substituents are diethyl aminoethyl substituents.
- the method is useful for preparing analogs where the substituents on the ring nitrogen are the same or different and where they may include alkyl groups which contain one or more heteroatoms such as N or O or which may contain non-interfering substituents such as RO, R 2 N, wherein R is alkyl (1-4C or H), preferably alkyl 1-4C, or substituted by one or more alkyl groups.
- the substituents at the ring nitrogen can be any substituents wherein the components of the substituent do not interfere with the overall reaction scheme described herein.
- the substituents at the ring nitrogen are essentially alkyl (1-10C) with one or two optional heteroatoms selected from O and N, and further substituted by basic or neutral substituents.
- the substituents on the ring nitrogen may include aryl groups which themselves may be optionally substituted; it is preferred that the aryl groups be present in the form of arylalkyl. In the case of some substituents, it may be necessary to protect the substituents during some phases of the preparation procedure. Methods for protection and de-protection of such substituents are well-known in the art.
- hydrochloride salt of the DSPDA and hydrochloric acid is used where acidification is required, it is not necessary to use this particular salt.
- HCl is preferred; however, alternative salts include inorganic salts such as the hydrobromide, the nitrate, or hydrofluoride; salts of organic acids, such as acetates, propionates, glycolates and the like may also be used.
- N,n-dibutyl-p-nitrosoaniline hydrochloride (5 g; 0.00196 moles prepared in Example 1 was dissolved in 1:2 HCl (60 ml; 0.24M of HCl) (Solution C).
- Zn dust (5.12 g; 0.0784 moles) was gradually added to the magnetically stirred Solution C placed in a two-neck round-bottom flask (150-250 ml volume) fitted with a reflux condenser. When all the Zn was added, the mixture was heated for an additional hour on a water bath. The reduction was completed when the supernatant was colorless after allowed Zn to settle. Excess zinc dust was collected on a Buchner funnel and washed with warm dilute (4:4) HCl.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
- The invention relates to an improved synthesis of N,N-disubstituted-p-phenylenediamine, especially the dibutyl form (DBPDA). DBPDA is a useful reagent in colorometric and fluorescence assays.
- U.S. Pat. No. 6,066,467, the contents of which are incorporated by reference, discloses the use of a particular N,N-disubstituted-p-phenylene diamine, DBPDA, in a fluorescence assay for hydrogen sulfide production from the action of homocysteinase. The assay, which is useful to measure homocysteine levels in bodily fluids, shows enhanced sensitivity over similar assays which utilize absorbance by color. Such assays are described in U.S. Pat. No. 5,998,191 and U.S. Pat. No. 5,985,540, also incorporated by reference. The colorometric reagent counterparts to DBPDA, in addition to this dibutyl derivative, can also be N,N-dipropyl-1,4-phenylenediamine or the corresponding diethyl or dimethyl derivative.
- While the dibutyl derivative, DBPDA, is available commercially, it is not as inexpensive or obtainable in as great quantity as the lower alkyl counterparts. Accordingly, an improved synthesis for DBPDA would be of benefit.
- A classic synthesis for this compound is described in Reilly, J. and Hickinbottom, W. J. inJ.Chem.Soc. (London) (1918) pages 99-111. Two methods are described for the synthesis; of greater relevance to the present invention is the conversion of di-n-butylaniline to the para-nitroso compound with subsequent reduction to the desired product. It has now been found that the described method is unworkable as strictly described, as it is necessary to conduct certain steps of the reaction in an oxygen-free environment. In addition, an improved method for crystallization is described herein. These improvements are applicable to N,N-disubstituted-p-phenylene diamine (DSPDA) generally.
- The invention is directed to an improvement over the literature-described synthesis of di-n-butyl-p-phenylenediamine and its salts, as well as DSPDA in general. The improved method, like that described in the prior art, employs the conversions shown in FIG. 1. Both the intermediate nitroso-compound and the phenylenediamine derivative that is the final product can be converted to the acid addition salts using standard techniques. According to the method of the present invention, certain steps in this reaction are conducted in an oxygen-free environment.
- Thus, in one aspect, the invention is directed to an improved method to synthesize DSPDA, especially DBPDA, which method comprises treating p-nitroso disubstituted aniline with a reducing agent, and working up the product in the absence of oxygen. In a preferred embodiment, the reducing agent is zinc. Further, the production of the nitroso compound is preferably from treating disubstituted aniline starting material with nitrous acid.
- In another aspect, the invention is directed to an improved method to crystallize DSPDA, especially DBPDA, which method comprises treating an absolute ethanol solution of the dihydrochloride with ether.
- FIG. 1 shows the steps in the conversion of di-n-butylaniline to DBPDA.
- In a preferred embodiment, to prepare the nitroso intermediate, an aqueous solution of the starting material, preferably di-n-butylaniline is acidified with concentrated acid, preferably HCl, and then treated with sodium nitrite. The temperature is kept low, preferably at 0° C., and the addition of sodium nitrite to the starting material solution is performed with stirring over 1-2 hours. The crude hydrochloride product precipitates from solution and may, if desired, be re-crystallized.
- The recovered di-n-butyl-p-nitrosoaniline hydrochloride prepared is then dissolved in hydrochloric acid and a reducing agent added. A preferred reducing agent is excess zinc dust, although other reducing agents, such as H2 could also be used. When the reduction is complete, the zinc metal is filtered off. It is essential to the method of the invention that the filtrate, from then on, is kept under an atmosphere which excludes oxygen. The filtrate is neutralized with strong base. If zinc is used as a reducing agent, the zinc ion formed initially precipitates and then re-dissolves. During this process, the reaction mixture is kept under nitrogen or other method to exclude oxygen is employed. This also converts the product to the free amine which can then be extracted in a suitable organic solvent, such as ether. These operations, too, must be performed in the absence of oxygen. The non-aqueous layer is then dried and treated with non-aqueous acid to effect precipitation of the salt, preferably the hydrochloride salt of the desired product.
- The hydrochloride salt can then be crystallized by dissolving in an alcoholic solvent in the absence of water and in the absence of oxygen and effecting crystallization by addition of ether.
- If desired, the DBPDA product can be refluxed in acetone at 70-80° for about two hours.
- The resulting DBPDA is useful as a reagent for the colorometric or fluorescence detection of hydrogen sulfide in the presence of a metal ion, such as ferric ion, as described in the above-cited art.
- As is known in the art, in addition to DBPDA, other dialkyl substituted phenylene diamines are useful in fluorescence detection of hydrogen sulfide in the presence of a metal ion or other oxidizing agent. Thus, the method described above with particularity for DBPDA is also useful for N,N-disubstituted phenylene diamines in general which also have utility as detection reagents in such assays. Thus, in addition to the di-n-butyl substituted form, the method could be applied to any dialkyl substituted form, as well as forms of the phenylene diamine which have substituents on the ring nitrogen which may themselves be substituted alkyl groups. Thus, for example, also illustrated below is the synthesis of the N,N-disubstituted phenylene diamine wherein the substituents are diethyl aminoethyl substituents.
- Thus, in general, the method is useful for preparing analogs where the substituents on the ring nitrogen are the same or different and where they may include alkyl groups which contain one or more heteroatoms such as N or O or which may contain non-interfering substituents such as RO, R2N, wherein R is alkyl (1-4C or H), preferably alkyl 1-4C, or substituted by one or more alkyl groups. The substituents at the ring nitrogen can be any substituents wherein the components of the substituent do not interfere with the overall reaction scheme described herein. In general, the substituents at the ring nitrogen are essentially alkyl (1-10C) with one or two optional heteroatoms selected from O and N, and further substituted by basic or neutral substituents.
- In addition, the substituents on the ring nitrogen may include aryl groups which themselves may be optionally substituted; it is preferred that the aryl groups be present in the form of arylalkyl. In the case of some substituents, it may be necessary to protect the substituents during some phases of the preparation procedure. Methods for protection and de-protection of such substituents are well-known in the art.
- In addition, while the method of the invention is illustrated using the hydrochloride salt of the DSPDA and hydrochloric acid is used where acidification is required, it is not necessary to use this particular salt. HCl is preferred; however, alternative salts include inorganic salts such as the hydrobromide, the nitrate, or hydrofluoride; salts of organic acids, such as acetates, propionates, glycolates and the like may also be used.
- The following examples are intended to illustrate but not to limit the invention.
- A solution of N,N-dibutylaniline (10.25 g; 0.05 moles; Aldrich No.: 30,446-8, 97%) in a mixture of concentrated HCl (15 ml; Aldrich No.: 25,814-8, 37%) and distilled water (20 ml) was cooled to −5° C. to −15° C. in a freezing mixture (ice+salt) (Solution A). Sodium nitrite (3.62 g; 0.052 moles; Aldrich No: 43,089-9, granular, 99.5%, DuPont product) was dissolved at room temperature in distilled water (10 ml) and cooled to and kept at 0° C. (Solution B). Cold (0° C.) Solution B was gradually added over 1-2 hours to a magnetically stirred Solution A (at −5 to −15° C.) and the reaction temperature was carefully monitored and not allowed to rise above 0° C. During addition, the reaction mixture changes from pale red to almost black. The mixture was then allowed to attain room temperature over two to three hours. During this time, a dark crystalline mass was deposited. The crystals were collected on Buchner funnel and washed with acetone.
- The crystalline mass was dried in vacuum at 40° C. to constant weight. The average yield of the crude product title compound was almost quantitative (10.5 g). The crude product was dissolved in a minimum amount of ethanol (usually around 20 ml absolute ethanol) and pure product precipitated with ether (150-200 ml, 99+%). The yield of the pure product (yellow-greenish crystals) was between 8 and 9 g (80-90% theoretical).
- N,n-dibutyl-p-nitrosoaniline hydrochloride (5 g; 0.00196 moles prepared in Example 1 was dissolved in 1:2 HCl (60 ml; 0.24M of HCl) (Solution C). Zn dust (5.12 g; 0.0784 moles) was gradually added to the magnetically stirred Solution C placed in a two-neck round-bottom flask (150-250 ml volume) fitted with a reflux condenser. When all the Zn was added, the mixture was heated for an additional hour on a water bath. The reduction was completed when the supernatant was colorless after allowed Zn to settle. Excess zinc dust was collected on a Buchner funnel and washed with warm dilute (4:4) HCl.
- The following steps until recovery of the final product as crystals were carried out in the absence of oxygen. Where possible, the steps were performed under an atmosphere of nitrogen; in some cases, when it was impractical to maintain a nitrogen atmosphere (such as extraction into an organic solvent) the operations were conducted rapidly and with minimal exposure to air. The filtrate was treated with excess concentrated NaOH (50% solution in water) under a nitrogen atmosphere until the initially precipitated zinc hydroxide was dissolved. The oily suspended reduction product was extremely sensitive to oxygen and in its presence the product immediately turns from pale to dark blue. If the process is done correctly, excluding oxygen, the product is almost colorless or slightly pale blue.
- The whole reaction mixture was then carefully transferred to a separatory funnel, and the basic final product was extracted with several portions of ether (each portion of 50-70 ml), in the absence of oxygen with minimum shaking.
- The collected ether layer was dried over anhydrous K2CO3 overnight, under N2. (The product is also very sensitive to moisture.) Ether solution was filtered off from the drying agent, which was washed with ether (the whole operation should be done as quickly as possible) and the filtrate was treated with an excess of anhydrous HCl in ether (50-70 ml, 1.0 M, solution in diethyl ether. Ethanol (20-40 ml) was also added to promote crystallization. The product crystals were collected with a Buchner funnel and dried as soon as possible under N2.
- If the just-described operations are done strictly excluding oxygen and moisture, the obtained product is an almost colorless crystalline substance, and the yield is 3.5-4 g.
- To recrystallize the product, the crude DBPDA HCl was dissolved in a minimum of ethanol and ether was added to crystallize.
- A. Preparation of 4-nitro-N,N-bis[2-(N′,N′-diethylamino)ethyl]aniline: 1-fluoro-4-nitrobenzene in is dissolved in N,N-dimethylformamide (DMF) in a 100 ml flask. The solution is stirred magnetically, and then N,N,N′N′-tetraethyldiethylenetriamine is added to the solution. The mixture is heated for 2 h at 110° C., and then cooled to room temperature. The product is extracted with hexane and purified on a silica gel column.
- B. Preparation of 4-amino-N,N-bis[2-(N′,N′-diethylamino)ethyl]aniline: The 4-nitro-N,N-bis[2-(N′,N′-diethylamino)ethyl]aniline from paragraph A is dissolved in 1:2 HCl in 200 ml in a two-neck flask. The solution is refluxed with stirring. Zn is added to the solution slowly, and the mixture is kept boiling until the solution becomes colorless. A solution of 50% NaOH is added under N2 until the white precipitate dissolves. The product is extracted with ether and crystallized HCl/ether under N2.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/760,202 US6448446B1 (en) | 2000-01-12 | 2001-01-12 | Synthesis of N,N-disubstituted-p-phenylenediamine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17574200P | 2000-01-12 | 2000-01-12 | |
US09/760,202 US6448446B1 (en) | 2000-01-12 | 2001-01-12 | Synthesis of N,N-disubstituted-p-phenylenediamine |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020026080A1 true US20020026080A1 (en) | 2002-02-28 |
US6448446B1 US6448446B1 (en) | 2002-09-10 |
Family
ID=22641450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/760,202 Expired - Lifetime US6448446B1 (en) | 2000-01-12 | 2001-01-12 | Synthesis of N,N-disubstituted-p-phenylenediamine |
Country Status (9)
Country | Link |
---|---|
US (1) | US6448446B1 (en) |
EP (1) | EP1265846B1 (en) |
JP (1) | JP4756806B2 (en) |
KR (1) | KR100682292B1 (en) |
AT (1) | ATE269843T1 (en) |
AU (2) | AU2946001A (en) |
CA (1) | CA2389595C (en) |
DE (1) | DE60103986T2 (en) |
WO (1) | WO2001051452A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6329162B1 (en) * | 1999-04-16 | 2001-12-11 | Anticancer, Inc. | Biological fluid assay methods |
KR100692623B1 (en) | 2006-04-25 | 2007-03-14 | 충남대학교산학협력단 | Aromatic amino polymers for chemical sensor and reaction intermediate, and composition containing them |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5444622A (en) * | 1977-09-13 | 1979-04-09 | Toyo Soda Mfg Co Ltd | Stabilization of aromatic diamine |
US5985540A (en) * | 1997-07-24 | 1999-11-16 | Anticancer, Inc. | High specificity homocysteine assays for biological samples |
US6066467A (en) * | 1997-07-24 | 2000-05-23 | Anticancer, Inc. | High specificity homocysteine assays for biological samples |
JP3327241B2 (en) * | 1998-02-12 | 2002-09-24 | 富士レビオ株式会社 | Reagents and methods for measuring hydrogen sulfide |
JP2000007622A (en) * | 1998-06-26 | 2000-01-11 | Mitsui Chemicals Inc | Storage and transportation of aromatic diamine |
-
2001
- 2001-01-12 CA CA2389595A patent/CA2389595C/en not_active Expired - Fee Related
- 2001-01-12 DE DE60103986T patent/DE60103986T2/en not_active Expired - Lifetime
- 2001-01-12 EP EP01942355A patent/EP1265846B1/en not_active Expired - Lifetime
- 2001-01-12 KR KR1020027008993A patent/KR100682292B1/en active IP Right Grant
- 2001-01-12 WO PCT/US2001/001191 patent/WO2001051452A1/en active IP Right Grant
- 2001-01-12 AU AU2946001A patent/AU2946001A/en active Pending
- 2001-01-12 US US09/760,202 patent/US6448446B1/en not_active Expired - Lifetime
- 2001-01-12 AT AT01942355T patent/ATE269843T1/en not_active IP Right Cessation
- 2001-01-12 JP JP2001551834A patent/JP4756806B2/en not_active Expired - Fee Related
- 2001-01-12 AU AU2001229460A patent/AU2001229460B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2389595A1 (en) | 2001-07-19 |
JP4756806B2 (en) | 2011-08-24 |
EP1265846A1 (en) | 2002-12-18 |
WO2001051452A1 (en) | 2001-07-19 |
US6448446B1 (en) | 2002-09-10 |
AU2946001A (en) | 2001-07-24 |
DE60103986T2 (en) | 2005-06-30 |
CA2389595C (en) | 2011-05-24 |
KR20020063305A (en) | 2002-08-01 |
JP2003524639A (en) | 2003-08-19 |
AU2001229460B2 (en) | 2004-12-09 |
KR100682292B1 (en) | 2007-02-15 |
EP1265846B1 (en) | 2004-06-23 |
ATE269843T1 (en) | 2004-07-15 |
DE60103986D1 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1563842A (en) | Phenyl-acetic acids and derivatives thereof | |
AU2006271645B2 (en) | Method for preparing 4beta-amino-4'-demethyl-4-desoxypodophyllotoxin | |
US8318936B2 (en) | Method for producing N-methylnaltrexone bromide | |
WO2009064084A2 (en) | Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts | |
US7667071B2 (en) | Process for the preparation of gabapentin hydrochloride | |
CA2463146A1 (en) | Crystalline sodium salt of telmisartan and the use of same as an angiotensin antagonist | |
US6448446B1 (en) | Synthesis of N,N-disubstituted-p-phenylenediamine | |
CN110511159B (en) | Synthesis method of benserazide hydrochloride | |
AU2001229460A1 (en) | Improved synthesis of N,N-disubstituted-p-phenylenediamine | |
RU2546674C2 (en) | 2-mercaptobenztellurazoles and method for production thereof | |
CA2608087A1 (en) | Methods for synthesizing heterocyclic compounds | |
US8362269B2 (en) | Preparation of 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole | |
EP2139899B1 (en) | Crystalline forms of topotecan hydrochloride and processes for making the same | |
US8697886B2 (en) | Di(aminoguanidium) 4,4′,5,5′-tetranitro-2,2′-biimidazole, and preparation method thereof | |
CN108409635B (en) | Carbazole fluorescent thymine drug labeling reagent, synthesis and application | |
CN109970569A (en) | A kind of preparation method of N, N- dimethyl-p-phenylenediamine's hydrochloride | |
JP4245490B2 (en) | 2- (Dichlorophenyl) -4-phenylimidazole compound | |
JP3303050B2 (en) | Azonia adamantane compound, method for producing azaadamantane compound therefrom and method for producing said azoniaadamantane compound | |
KR100351743B1 (en) | Process for preparation of the n,n-dicyclohexyl-2-benzothiazole sulfenamide | |
CN109180511A (en) | A kind of preparation method of tetracaine hydrochloride | |
IE49529B1 (en) | Preparation of 5-hydroxymethylimidazoles | |
SU420615A1 (en) | METHOD FOR OBTAINING 2,4-DINITRO-3-AMINO-K-PHENYL HYDROXYLAMINE 12 A method is proposed for preparing 2,4-dinitro-3-amino-N-phenyl-hydroxylamine, which can be used in organic synthesis, in particular in the synthesis of aniline dyes , as well as in the synthesis of polymers. A method of producing phenylhydroxyl-silamine by reducing nitrobenzene with hydrogen in the presence of skeletal nickel, alkali metal sulphate salts and aniline is known. xylamine - a derivative of 2,4-dinitrobenzene, obium of formula 10, where R is an alkoxy group, is reacted with hydroxylamine and an alkali metal alcohol in an alcohol solution, followed by hydrolysis of the complex compound formed and the release of the desired product in its free form as known in a way. The reaction takes place at room temperature for 5-10 minutes with a yield of 80% according to the following scheme: | |
JP4480245B2 (en) | Cyclic aniline sulfide and method for producing the same | |
ITTO20080018A1 (en) | PROCEDURE FOR FURFURAL PREPARATION. | |
US20140066630A1 (en) | Process for the preparation of bis-(1(2)h-tetrazol-5-yl)-amine monohydrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ANTICANCER, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TANG, LI;TAN, YUYING;REEL/FRAME:011814/0880 Effective date: 20010502 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REFU | Refund |
Free format text: REFUND - PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: R1551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 12 |
|
SULP | Surcharge for late payment |
Year of fee payment: 11 |